258 results on '"Wraith, David C"'
Search Results
2. Symptoms and risk factors for long COVID in non-hospitalized adults
3. Antigen-specific immunotherapy with apitopes suppresses generation of FVIII inhibitor antibodies in HLA-transgenic mice
4. Autoantigens in rheumatoid arthritis and the potential for antigen-specific tolerising immunotherapy
5. Designing antigens for the prevention and treatment of autoimmune diseases
6. Negative Selection during the Peripheral Immune Response to Antigen
7. SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection.
8. Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice
9. Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis
10. CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire
11. CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice
12. Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis
13. A Role for Galanin in Human and Experimental Inflammatory Demyelination
14. Enhanced Selection of FoxP3⁺ T-Regulatory Cells Protects CTLA-4-Deficient Mice from CNS Autoimmune Disease
15. Antigen-specific immunotherapy of autoimmune and allergic diseases
16. Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy
17. A Single Amino Acid Change in a Myelin Basic Protein Peptide Confers the Capacity to Prevent Rather than Induce Experimental Autoimmune Encephalomyelitis
18. SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation.
19. The adaptive immune system in diseases of the central nervous system
20. Adaptive T cell tuning in immune regulation and immunotherapy of autoimmune diseases✰.
21. Vaccination and autoimmune disease: what is the evidence?
22. Peptide-based therapy for autoimmune diseases
23. IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE
24. Human Mesenchymal Stem Cells Infiltrate the Spinal Cord, Reduce Demyelination, and Localize to White Matter Lesions in Experimental Autoimmune Encephalomyelitis
25. Preclinical models of arthritis for studying immunotherapy and immune tolerance.
26. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs
27. Avidity and the Art of Self Non-Self Discrimination
28. Experimental autoimmune encephalomyelitis in mice expressing the autoantigen MBP1–10 covalently bound to the MHC class II molecule I-Au
29. Complete characterization of the expressed immune response genes in Biozzi AB/H mice: structural and functional identity between AB/H and NOD A region molecules
30. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein
31. Regulatory CD4 + T cells and the control of autoimmune disease
32. Activation thresholds determine susceptibility to peptide-induced tolerance in a heterogeneous myelin-reactive T cell repertoire
33. A role for major histocompatibility complex-binding peptides in the immunotherapy of autoimmune disease
34. Induction of Tolerance to Therapeutic Proteins With Antigen-Processing Independent T Cell Epitopes: Controlling Immune Responses to Biologics.
35. Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva.
36. Establishing the prevalence of common tissue‐specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection.
37. SARS‐CoV‐2‐specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi‐System Syndrome.
38. T-cell receptor degeneracy: the dog that did not bark: Adaptation of the self-reactive T-cell response to limit autoimmune disease
39. Natural and Induced Regulatory T Cells
40. Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in Th1 and Th2 cells
41. Peptides containing a dominant T-cell epitope from red cell band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune hemolytic anemia
42. Manipulating antigen presentation for antigen-specific immunotherapy of autoimmune diseases.
43. Peptide allergen‐specific immunotherapy for allergic airway diseases—State of the art.
44. The Mechanism of Action of Antigen Processing Independent T Cell Epitopes Designed for Immunotherapy of Autoimmune Diseases.
45. TUNING THE PERIPHERAL IMMUNE RESPONSE TO ANTIGEN.
46. USING ALTERED PEPTIDE LIGANDS TO ASSESS THE LIMITS OF T-CELL PROMISCUITY
47. A humanized HLA-DR4 mouse model for autoimmune myocarditis
48. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response.
49. Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases.
50. Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.